| scholarly article | Q13442814 |
| P2093 | author name string | Michael A Mathier | |
| Richard P Shannon | |||
| Lazaros A Nikolaidis | |||
| You-Tang Shen | |||
| Aaron Doverspike | |||
| Dennis Trumble | |||
| Rhonda Huerbin | |||
| Teresa Hentosz | |||
| P2860 | cites work | Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy | Q28368321 |
| Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group | Q33157410 | ||
| Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure | Q33892916 | ||
| Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response | Q36425838 | ||
| Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study | Q39389283 | ||
| Beta-adrenoceptor desensitization during the development of canine pacing-induced heart failure | Q41183380 | ||
| Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. | Q42463973 | ||
| Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction | Q42557272 | ||
| Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy | Q43651420 | ||
| Exaggerated chronotropic and energetic response to dobutamine after orthotopic cardiac transplantation | Q43705327 | ||
| Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine | Q44186068 | ||
| The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study | Q44843009 | ||
| Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). | Q53344976 | ||
| Cardiac work and efficiency. | Q53710150 | ||
| Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. | Q54395816 | ||
| Effects of Dobutamine Stimulation on Myocardial Blood Flow, Glucose Metabolism, and Wall Motion in Normal and Dysfunctional Myocardium | Q58071884 | ||
| P433 | issue | 4 | |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| P304 | page(s) | 409-419 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure). | |
| P478 | volume | 6 |
Search more.